Reckitt Benckiser consensus picture, analysts stay cautious on the shares

Reckitt Benckiser sits in a mature consumer staples niche, with a mixed analyst view on the London?listed shares and a clear focus on margins, cash generation and brand investment.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 14:56.

Reckitt Benckiser Group (GB00B24CGK77) is a long-established household and personal care company listed in London, with the shares trading under the ticker RKT on the LSE. The stock sits in the consumer staples sector, which many analysts view as defensive but fairly valued today.

What recent results showed

Reckitt last presented full-year figures for 2024 in an announcement filed in early March 2025, outlining top- and bottom-line growth and strong cash returns to shareholders. In that release, the company highlighted a return on capital employed of 13.5 percent for 2024, around 100 basis points higher than the 12.5 percent reported for 2023. The update reaffirmed management’s strategic priorities of brand investment, productivity and disciplined capital allocation in the consumer health, hygiene and nutrition segments.

The company’s investor presentation took place at the London Stock Exchange on the morning of the results day, underlining its status as a core constituent of the UK-listed consumer names alongside peers such as Unilever and Procter & Gamble. For retail investors, the published figures and commentary provide a useful baseline for assessing how much of Reckitt’s margin and growth story is already priced into the shares.

Analyst stance on Reckitt

Coverage of the Reckitt Benckiser stock by major houses such as Goldman Sachs, JPMorgan and UBS typically focuses on organic sales growth, gross margin resilience and cash conversion. The broad consensus has tended to rate the shares around Hold, with valuation multiples seen as reflecting the company’s solid but mature growth profile according to recent market commentary on large-cap consumer staples. In this context, analysts often compare Reckitt’s performance and valuation with sector peers in the European staples universe, including Unilever and Nestlé, to gauge relative attractiveness.

Many notes also emphasize execution risks in categories such as over-the-counter health and infant nutrition, where regulation, competition and demographic trends can affect volume growth and pricing power. At the same time, the consensus view acknowledges the robustness of Reckitt’s global brand portfolio, diversified geographic exposure and strong free cash flow generation, which underpin the capacity for dividends and buybacks as part of the capital allocation framework.

The products behind the stock

Reckitt generates revenue from a broad portfolio of branded consumer products in health, hygiene and nutrition, ranging from disinfectants and surface cleaners to over-the-counter medicines and infant formula. Well-known brands include Dettol in hygiene, Nurofen in pain relief and Durex in sexual health, all positioned in categories with recurring demand and high brand recognition.

Where the shares trade today

Reckitt Benckiser Group shares (GB00B24CGK77) are listed on the London Stock Exchange under the ticker RKT, trading in British pounds alongside other large-cap consumer staples such as Unilever in the FTSE 100 index. The current price level reflects the market’s view on the company’s earnings, cash generation and strategic execution at this point in the cycle.

Key data on the Reckitt Benckiser shares

• Company: Reckitt Benckiser Group PLC
• ISIN: GB00B24CGK77
• WKN: A1WY43
• Ticker: RKT
• Trading venue: London Stock Exchange
• Price (as of 2026-06-23, 14:30): 54.20 GBP
• Market cap: 38.0 billion GBP (as of 2026-06-23)
• Sector / industry: Consumer Staples / Personal & Household Products
• Index membership: FTSE 100
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice, a recommendation or a solicitation to buy or sell any securities. All data are based on publicly available sources believed to be reliable at the time of writing, but may change without notice.